Jean‐Michel Rivet

The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

Mark J. Millan, Alain P. Gobert, F. Lejeune et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 512 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

Alain P. Gobert, Jean‐Michel Rivet, Adrian Newman‐Tancredi et al. · Synapse · 2000 · 336 citations

Medicine, Neuroscience, Pharmacology +17

Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release

Alain P. Gobert, Jean‐Michel Rivet, Valérie Audinot et al. · Neuroscience · 1998 · 204 citations

Life Sciences, Neurobiology, Neuroscience +17

Agonist and antagonist actions of yohimbine as compared to fluparoxan at ?2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states

Mark J. Millan, Adrian Newman‐Tancredi, Val�rie Audinot et al. · Synapse · 2000 · 193 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Glial D-Serine Gates NMDA Receptors at Excitatory Synapses in Prefrontal Cortex

Pascal Fossat, Fabrice Turpin, Silvia Sacchi et al. · Cerebral Cortex · 2011 · 185 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17